SVB Leerink Starts Denali Therapeutics Inc. (DNLI) at Outperform
Tweet Send to a Friend
(Updated - January 30, 2023 6:54 AM EST)
SVB Leerink analyst Marc Goodman initiates coverage on Denali Therapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
SVB Leerink analyst Marc Goodman initiates coverage on Denali Therapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
